vs
Side-by-side financial comparison of Leslie's, Inc. (LESL) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $147.1M, roughly 1.1× Leslie's, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs -56.4%, a 127.6% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs -16.0%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $-85.5M).
Leslie's, Inc., operating as Leslie's Swimming Pool Supplies, is the largest retailer of swimming pool supplies and related products. The company is headquartered in Phoenix, Arizona, and has a particularly strong retail presence in Arizona, California, Florida, Georgia and Texas.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
LESL vs STOK — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $147.1M | $158.6M |
| Net Profit | $-83.0M | $112.9M |
| Gross Margin | 18.4% | — |
| Operating Margin | -46.7% | 70.2% |
| Net Margin | -56.4% | 71.2% |
| Revenue YoY | -16.0% | 3661.1% |
| Net Profit YoY | -86.2% | 528.0% |
| EPS (diluted) | $-8.92 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $147.1M | — | ||
| Q4 25 | $389.2M | — | ||
| Q2 25 | $500.3M | — | ||
| Q1 25 | $177.1M | $158.6M | ||
| Q4 24 | $175.2M | $22.6M | ||
| Q3 24 | $397.9M | — | ||
| Q2 24 | $569.6M | — | ||
| Q1 24 | $188.7M | — |
| Q1 26 | $-83.0M | — | ||
| Q4 25 | $-162.8M | — | ||
| Q2 25 | $21.7M | — | ||
| Q1 25 | $-51.3M | $112.9M | ||
| Q4 24 | $-44.6M | $-10.5M | ||
| Q3 24 | $-9.9M | — | ||
| Q2 24 | $60.6M | — | ||
| Q1 24 | $-34.6M | — |
| Q1 26 | 18.4% | — | ||
| Q4 25 | 38.6% | — | ||
| Q2 25 | 39.6% | — | ||
| Q1 25 | 24.8% | — | ||
| Q4 24 | 27.2% | — | ||
| Q3 24 | 36.0% | — | ||
| Q2 24 | 40.2% | — | ||
| Q1 24 | 28.8% | — |
| Q1 26 | -46.7% | — | ||
| Q4 25 | -38.6% | — | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | -27.3% | 70.2% | ||
| Q4 24 | -22.7% | -60.4% | ||
| Q3 24 | 6.6% | — | ||
| Q2 24 | 17.2% | — | ||
| Q1 24 | -16.2% | — |
| Q1 26 | -56.4% | — | ||
| Q4 25 | -41.8% | — | ||
| Q2 25 | 4.3% | — | ||
| Q1 25 | -29.0% | 71.2% | ||
| Q4 24 | -25.4% | -46.4% | ||
| Q3 24 | -2.5% | — | ||
| Q2 24 | 10.6% | — | ||
| Q1 24 | -18.3% | — |
| Q1 26 | $-8.92 | — | ||
| Q4 25 | $-20.59 | — | ||
| Q2 25 | $0.12 | — | ||
| Q1 25 | $-0.28 | $1.90 | ||
| Q4 24 | $-4.82 | $-0.15 | ||
| Q3 24 | $-2.46 | — | ||
| Q2 24 | $0.33 | — | ||
| Q1 24 | $-0.19 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $274.8M |
| Total DebtLower is stronger | $781.6M | — |
| Stockholders' EquityBook value | $-489.9M | $350.1M |
| Total Assets | $649.4M | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $3.6M | — | ||
| Q4 25 | $64.3M | — | ||
| Q2 25 | $42.7M | — | ||
| Q1 25 | $17.3M | $274.8M | ||
| Q4 24 | $11.6M | $128.0M | ||
| Q3 24 | $108.5M | — | ||
| Q2 24 | $74.4M | — | ||
| Q1 24 | $8.4M | — |
| Q1 26 | $781.6M | — | ||
| Q4 25 | $756.6M | — | ||
| Q2 25 | $776.6M | — | ||
| Q1 25 | $858.1M | — | ||
| Q4 24 | $796.6M | — | ||
| Q3 24 | $783.7M | — | ||
| Q2 24 | $783.7M | — | ||
| Q1 24 | $882.7M | — |
| Q1 26 | $-489.9M | — | ||
| Q4 25 | $-408.0M | — | ||
| Q2 25 | $-246.2M | — | ||
| Q1 25 | $-269.5M | $350.1M | ||
| Q4 24 | $-220.0M | $229.0M | ||
| Q3 24 | $-177.1M | — | ||
| Q2 24 | $-168.2M | — | ||
| Q1 24 | $-231.0M | — |
| Q1 26 | $649.4M | — | ||
| Q4 25 | $741.5M | — | ||
| Q2 25 | $989.5M | — | ||
| Q1 25 | $1.0B | $406.9M | ||
| Q4 24 | $967.0M | $271.6M | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-81.1M | $131.8M |
| Free Cash FlowOCF − Capex | $-85.5M | $131.7M |
| FCF MarginFCF / Revenue | -58.1% | 83.0% |
| Capex IntensityCapex / Revenue | 2.9% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | $7.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $-81.1M | — | ||
| Q4 25 | $48.2M | — | ||
| Q2 25 | $114.9M | — | ||
| Q1 25 | $-49.2M | $131.8M | ||
| Q4 24 | $-105.1M | $-23.2M | ||
| Q3 24 | $47.1M | — | ||
| Q2 24 | $175.5M | — | ||
| Q1 24 | $-43.2M | — |
| Q1 26 | $-85.5M | — | ||
| Q4 25 | $41.8M | — | ||
| Q2 25 | $107.1M | — | ||
| Q1 25 | $-55.8M | $131.7M | ||
| Q4 24 | $-109.8M | $-23.2M | ||
| Q3 24 | $34.1M | — | ||
| Q2 24 | $165.2M | — | ||
| Q1 24 | $-56.5M | — |
| Q1 26 | -58.1% | — | ||
| Q4 25 | 10.7% | — | ||
| Q2 25 | 21.4% | — | ||
| Q1 25 | -31.5% | 83.0% | ||
| Q4 24 | -62.6% | -102.7% | ||
| Q3 24 | 8.6% | — | ||
| Q2 24 | 29.0% | — | ||
| Q1 24 | -29.9% | — |
| Q1 26 | 2.9% | — | ||
| Q4 25 | 1.7% | — | ||
| Q2 25 | 1.6% | — | ||
| Q1 25 | 3.7% | 0.1% | ||
| Q4 24 | 2.7% | 0.2% | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | 7.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q2 25 | 5.29× | — | ||
| Q1 25 | — | 1.17× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.89× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
